483
Nippon Shikizai, Inc.Nippon Shikizai, Inc. – FDA 483, Aug 6, 2019
Record Details
An FDA inspection of Nippon Shikizai, Inc. in Tsukuba, Ibaraki, Japan, an OTC drug manufacturer, revealed significant deficiencies. Observations included inadequate cleaning validation for multi-product equipment, insufficient calibration of production scales, and a lack of written procedures for tracking and managing deviations by the quality assurance unit. These issues indicate potential risks to drug product quality and compliance with cGMP regulations.
View Company Profile
ID · 0040da34-6484-4aaa-bf62-b5462515b407
Other documents for Nippon Shikizai, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.